| Name | Dr. Martens |
|---|---|
| Epic | DOCS |
| Isin | GB00BL6NGV24 |
| Index | UK250 UK350 |
| Industry | Personal Goods |
| Latest share price | 57.30p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £551.85 | Debt ratio | n/a |
| Shares in issue | 961.97 | Debt-to-equity ratio | n/a |
| P/E ratio | 11 | Assets / equity ratio | n/a |
| Total dividends per share | 1.56p | Price to book value | n/a |
| Dividend yield | 4.1 | ROCE | 29.83 |
| Dividend cover | 2.21 | EPS growth | -26 |
| Earning per share | 12.9 | 52-week high / low | 50.55p / 114.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2024-01-04 | 2024-02-02 | 1.56p |
| Final | 2023-06-08 | 2023-07-18 | 4.28p |
| Interim | 2023-01-05 | 2023-02-03 | 1.56p |
| Final | 2022-06-09 | 2022-07-19 | 4.28p |
| Interim | 2022-01-13 | 2022-02-04 | 1.22p |
| Company name | Dr. Martens |
|---|---|
| Address | 28 Jamestown Road, Camden, London, United Kingdom, NW1 7BY |
| Telephone | |
| Website | http://www.drmartensplc.com |
| Director | Position |
|---|---|
| Mr Kenny Wilson | CEO |
| Mr Giles Wilson | CFO |
| Mr Paul Mason | Chairman |
| Ms Tara Alhadef | Non-Executive Director |
| Ms Lynne Weedall | Senior Independent Non-Executive Director |
| Mr Andrew Harrison | Independent Non-Executive Director |
| Miss Robyn Perriss | Independent Non-Executive Director |
| Mr Ian Rogers | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/03/23 | 31/03/22 | 31/03/21 |
| Intangible asssets and goodwill | 265.6 | 262.1 | 259.6 |
| Investments and other non-current assets | 1 | n/a | n/a |
| Total non-current assets | 483.8 | 415.5 | 377 |
| Inventory / work in progress | 257.8 | 123 | 101.5 |
| Trade and other receivables | 93 | 85.6 | 59.4 |
| Cash and equivalents | 157.5 | 228 | 113.6 |
| Other current assets and asset held for resale | 0.5 | 7 | 0.3 |
| Total of all assets | 992.6 | 859.1 | 651.8 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 164.5 | 155 | 152.3 |
| Long term liabilities | 423.9 | 375.9 | 349.8 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 588.4 | 530.9 | 502.1 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 404.2 | 328.2 | 149.7 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 10 | 10 | 10 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 1782.2 | 1711.3 | 1537.1 |
| Share premium account | n/a | n/a | n/a |
| Total equity | 404.2 | 328.2 | 149.7 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 176.2 | 229.3 | 112.5 |
| Pre-tax profit | 159.4 | 214.3 | 70.9 |